Clinical Trial

Cognitive Intervention for Cognitive Impairment

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Mild cognitive impairment is characterized by cognitive dysfunction without impairment in instrumental activities of daily living, with aging being the primary risk factor. Cognitive interventions employ stimulation and training techniques to address this impairment. Objective: To determine the effect of a cognitive intervention on mild cognitive impairment in older adults with type 2 diabetes mellitus. Methods: A double-blind, randomized clinical trial involving 102 patients, who will be assigned to either a control group or an intervention group. Data collection will utilize a sociodemographic profile questionnaire and the Montreal Cognitive Assessment (MoCA). The cognitive intervention will be implemented over an average period of two months per subgroup, consisting of eight weekly, 60-minute sessions. Analysis will be conducted using descriptive statistics, and a linear mixed-effects model for repeated measures will be applied to evaluate the intervention's effect.
Trial Details
NCT Number NCT07747675
Lead Sponsor Instituto Mexicano del Seguro Social
Conditions Cognitive Intervention, Mild Cognitive Impairment, Elderly Adults, Diabetes Mellitus
Enrollment 102 participants
Start Date 2026-08-03
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-05